Doctor profile · Federal record

Dr. Alexandra Heeren, APRN

Nurse Practitioner · Topeka, KS

  • NPI 1205226248
  • Accepts Medicare
  • MIPS 82.1 / 100 · 2023
  • 12 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
2921 Sw Wanamaker Dr
Topeka, KS 666145328
(785) 272-6860
fax (785) 272-5839
Additional location
2902 Sw Asbury Dr
Topeka, KS 666144466
(785) 270-0187
fax (785) 270-0168

Credentials & registration

NPPES · NUCC
NPI registered
January 2015 — 11 yrs on file
Profile last updated
February 17, 2026
Year of graduation
2014 — 12 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
Kansas #76686

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1205226248. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
7,795
Distinct HCPCS
10
Medicare allowed
$224,119
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 4,202 21 $2
17003 Destruction of precancer skin growth, 2-14 growths 1,007 206 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 877 608 $72
17000 Destruction of precancer skin growth, 1 growth 400 301 $43
99214 Established patient office or other outpatient visit, 30-39 minutes 322 244 $102
11102 Biopsy of related skin growth, first growth 216 193 $76
11104 Punch biopsy, first skin growth 138 126 $97
11103 Biopsy of related skin growth, each additional growth 110 69 $40
17110 Destruction of skin growth, 1-14 growths 86 68 $87
96573 Application of light by qualified health care professional to destroy precancer skin growth 73 66 $182

In context: peer comparison

Among 79 peers in Topeka Nurse Practitioner, average services per provider: 253. This provider delivers 31× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,998
Transactions
78
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 12 $454.04
Abbvie INC. 18 $292.12
Novartis Pharmaceuticals Corporation 10 $190.24
Janssen Biotech, INC. 5 $159.89
Regeneron Healthcare Solutions, INC. 5 $119.08
Ucb, INC. 5 $110.25
Sun Pharmaceutical Industries INC. 2 $109.76
Dermavant Sciences, INC. 5 $85.77
Incyte Corporation 3 $78.10
Leo Pharma INC. 4 $72.26
Almirall LLC 2 $51.44
ConvaTec INC. 1 $46.86
Boehringer Ingelheim Pharmaceuticals, INC. 2 $46.17
Lilly USA, LLC 2 $42.49
Amgen INC. 2 $40.82

By nature of payment

Food and Beverage
$1,735
Education
$263

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
615
Patients
294
Total drug cost
$75,256
Drug Type Claims Patients Total cost
Ketoconazole Generic 143 68 $3,743
Betamethasone Dipropionate Generic 100 55 $5,756
Hydrocortisone Generic 73 49 $476
Clobetasol Propionate Generic 51 27 $2,034
Doxycycline Hyclate Generic 45 15 $1,941
Hydroxyzine Hcl Generic 38 14 $400
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 27 11 $698
Fluorouracil Generic 25 20 $2,656
Clindamycin Phosphate Generic 24 12 $1,019
Tacrolimus Generic 18 0 $4,045

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Alexandra Heeren's medical specialty?
Dr. Alexandra Heeren practices Nurse Practitioner in Topeka, KS.
Where does Dr. Alexandra Heeren practice?
Dr. Alexandra Heeren practices at 2921 Sw Wanamaker Dr, Topeka, KS 666145328. Office phone: 7852726860.
What is Dr. Alexandra Heeren's NPI?
Dr. Alexandra Heeren's National Provider Identifier (NPI) is 1205226248, issued by NPPES.
Does Dr. Alexandra Heeren accept Medicare assignment?
Yes. Dr. Alexandra Heeren accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alexandra Heeren commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.